Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Macrogenics (MGNX)

Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript

MGNX earnings call for the period ending December 31, 2023.

MGNX : 14.96 (+5.20%)
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2023.

MGNX : 14.96 (+5.20%)
MacroGenics: Q3 Earnings Snapshot

MacroGenics: Q3 Earnings Snapshot

MGNX : 14.96 (+5.20%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 1.7000 (-1.16%)
MGNX : 14.96 (+5.20%)
IOVA : 14.10 (+0.36%)
MRTX : 58.70 (-0.17%)
MRSN : 4.49 (+4.42%)
DTCFF : 1.2240 (+2.00%)
LLY : 778.18 (+0.42%)
PFE : 27.78 (+0.69%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

DCPH : 15.18 (+2.43%)
MRTX : 58.70 (-0.17%)
MGNX : 14.96 (+5.20%)
Why Shares of MacroGenics Are Jumping Thursday

The company announced second-quarter earnings.

MGNX : 14.96 (+5.20%)
SNY : 49.54 (-0.42%)
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript

MGNX earnings call for the period ending June 30, 2023.

MGNX : 14.96 (+5.20%)
MacroGenics: Q2 Earnings Snapshot

MacroGenics: Q2 Earnings Snapshot

MGNX : 14.96 (+5.20%)
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript

MGNX earnings call for the period ending March 31, 2023.

MGNX : 14.96 (+5.20%)
MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of -157.01% and 81.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MGNX : 14.96 (+5.20%)
IMCC : 0.4112 (-9.75%)

Barchart Exclusives

IonQ vs. D-Wave: Which Quantum Computing Stock Has More Upside Potential?
In the growing quantum computing market, analysts expect IONQ stock to deliver significantly higher upside than QBTS. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar